Correlation Between MeVis Medical and Gamma Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MeVis Medical and Gamma Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MeVis Medical and Gamma Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MeVis Medical Solutions and Gamma Communications plc, you can compare the effects of market volatilities on MeVis Medical and Gamma Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MeVis Medical with a short position of Gamma Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of MeVis Medical and Gamma Communications.

Diversification Opportunities for MeVis Medical and Gamma Communications

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between MeVis and Gamma is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding MeVis Medical Solutions and Gamma Communications plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gamma Communications plc and MeVis Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MeVis Medical Solutions are associated (or correlated) with Gamma Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gamma Communications plc has no effect on the direction of MeVis Medical i.e., MeVis Medical and Gamma Communications go up and down completely randomly.

Pair Corralation between MeVis Medical and Gamma Communications

Assuming the 90 days trading horizon MeVis Medical is expected to generate 16.84 times less return on investment than Gamma Communications. But when comparing it to its historical volatility, MeVis Medical Solutions is 2.1 times less risky than Gamma Communications. It trades about 0.01 of its potential returns per unit of risk. Gamma Communications plc is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,794  in Gamma Communications plc on August 31, 2024 and sell it today you would earn a total of  76.00  from holding Gamma Communications plc or generate 4.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

MeVis Medical Solutions  vs.  Gamma Communications plc

 Performance 
       Timeline  
MeVis Medical Solutions 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MeVis Medical Solutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, MeVis Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Gamma Communications plc 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Gamma Communications plc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Gamma Communications is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

MeVis Medical and Gamma Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MeVis Medical and Gamma Communications

The main advantage of trading using opposite MeVis Medical and Gamma Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MeVis Medical position performs unexpectedly, Gamma Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gamma Communications will offset losses from the drop in Gamma Communications' long position.
The idea behind MeVis Medical Solutions and Gamma Communications plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance